Catalyst Financial Partners LLC Dexcom Inc Transaction History

Catalyst Financial Partners LLC

  • $511 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
BUY
$110.31 - $140.45 $9,817 - $12,500
89 Added 4.13%
2,244 $254 Million
Q1 2024

Apr 22, 2024
BUY
$114.22 - $140.1 $9,594 - $11,768
84 Added 4.06%
2,155 $288 Million
Q4 2023

Feb 06, 2024
BUY
$75.49 - $124.16 $156,339 - $257,135
2,071 New
2,071 $257 Million
Q2 2023

Aug 02, 2023
BUY
$112.47 - $130.98 $20,694 - $24,100
184 Added 10.44%
1,946 $250 Million
Q1 2023

Apr 11, 2023
BUY
$104.0 - $122.92 $183,248 - $216,585
1,762 New
1,762 $205 Million

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Catalyst Financial Partners LLC Portfolio

Follow Catalyst Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Financial Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email